|
||||||
|
 | |
| |
| Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples |
| |
| |
| The effects of the RNA editing to the stability of the RNA structures |
| |
| |
| |
| |
|
Editing gene: CCNH (CAeditome ID:902) |
Gene summary for CCNH |
 Gene summary |
| Gene information | Gene symbol | CCNH | Gene ID | 902 |
| Gene name | cyclin H | |
| Synonyms | CAK|CycH|p34|p37 | |
| Cytomap | 5q14.3 | |
| Type of gene | protein-coding | |
| Description | cyclin-HCAK complex subunitCDK-activating kinase complex subunitMO15-associated proteincyclin-dependent kinase-activating kinase complex subunit | |
| Modification date | 20210518 | |
| UniProtAcc | P51946 | |
| Context |
| Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Gene | GO ID | GO term | PubMed ID |
| CCNH | GO:0016251 | Cyclin-H | 7533895 |
| CCNH | GO:0006366 | Cyclin-H | 8692841 |
| CCNH | GO:0006366 | Cyclin-H | 9852112 |
| CCNH | GO:0006367 | Cyclin-H | 7533895 |
| CCNH | GO:0005654 | Cyclin-H | 0000052 |
| CCNH | GO:0000439 | Cyclin-H | 8692841 |
| CCNH | GO:0000439 | Cyclin-H | 8692842 |
| CCNH | GO:0005675 | Cyclin-H | 9852112 |
| CCNH | GO:0019907 | Cyclin-H | 8692841 |
| CCNH | GO:0019907 | Cyclin-H | 8692842 |
| CCNH | GO:0070516 | Cyclin-H | 8692841 |
| CCNH | GO:0070516 | Cyclin-H | 8692842 |
| CCNH | GO:0070985 | Cyclin-H | 8692841 |
Top |
RNA A-to-I events for CCNH |
| RNA A-to-I editing events across TCGA 33 cancers data sets based on Ensembl gene isoform structure. |
 |
| RNA editing frequencies across 33 cancers of gene: ENSG00000134480.12 |
| RNA A-to-I editing events in Cancer. |
| CAediting_419704(87392498, -), CAediting_419705(87392511, -), CAediting_419706(87392512, -), CAediting_419707(87394110, -), CAediting_419708(87394295, -), CAediting_419709(87394299, -), CAediting_419710(87394304, -), CAediting_419711(87396417, -), CAediting_419712(87396433, -), CAediting_419713(87396516, -), CAediting_419714(87396598, -), CAediting_419715(87397193, -), CAediting_419716(87397215, -), CAediting_419717(87397230, -), CAediting_419718(87397231, -), CAediting_419719(87397297, -), CAediting_419720(87397298, -), CAediting_419721(87398784, -), CAediting_419722(87398792, -), CAediting_419723(87406539, -), CAediting_419724(87412772, -), |
Top |
RNA editing positional annotations for CCNH using Annovar |
| Protein coding RNA editing(s). |
| CAeditome ID | Position | Variant type | ENST | NTchange | AAchange | SIFT_score | Polyphen2_HVAR_score | PROVEAN_pred |
| Gene structure information of RNA editing(s). |
| CAeditome ID | Position | Variant type |
| CAediting_419704 | chr5_87392498_- | ncRNA_exonic |
| CAediting_419705 | chr5_87392511_- | ncRNA_exonic |
| CAediting_419706 | chr5_87392512_- | ncRNA_exonic |
| CAediting_419707 | chr5_87394110_- | ncRNA_intronic |
| CAediting_419708 | chr5_87394295_- | ncRNA_exonic |
| CAediting_419709 | chr5_87394299_- | ncRNA_exonic |
| CAediting_419710 | chr5_87394304_- | ncRNA_exonic |
| CAediting_419711 | chr5_87396417_- | ncRNA_intronic |
| CAediting_419712 | chr5_87396433_- | ncRNA_intronic |
| CAediting_419713 | chr5_87396516_- | ncRNA_intronic |
| CAediting_419714 | chr5_87396598_- | ncRNA_intronic |
| CAediting_419715 | chr5_87397193_- | ncRNA_intronic |
| CAediting_419716 | chr5_87397215_- | ncRNA_intronic |
| CAediting_419717 | chr5_87397230_- | ncRNA_intronic |
| CAediting_419718 | chr5_87397231_- | ncRNA_intronic |
| CAediting_419719 | chr5_87397297_- | ncRNA_intronic |
| CAediting_419720 | chr5_87397298_- | ncRNA_intronic |
| CAediting_419721 | chr5_87398784_- | ncRNA_intronic |
| CAediting_419722 | chr5_87398792_- | ncRNA_intronic |
| CAediting_419723 | chr5_87406539_- | ncRNA_intronic |
| CAediting_419724 | chr5_87412772_- | exonic |
| Repat-regional RNA editing(s). |
| CAeditome ID | Position | Repeat family | Repeat sub family | Repeat name |
| CAediting_419711 | chr5_87396417_- | SINE | Alu | AluSc8 |
| CAediting_419712 | chr5_87396433_- | SINE | Alu | AluSc8 |
| CAediting_419713 | chr5_87396516_- | SINE | Alu | AluSc8 |
| CAediting_419714 | chr5_87396598_- | SINE | Alu | AluSc8 |
| CAediting_419715 | chr5_87397193_- | SINE | Alu | AluSx1 |
| CAediting_419716 | chr5_87397215_- | SINE | Alu | AluSx1 |
| CAediting_419717 | chr5_87397230_- | SINE | Alu | AluSx1 |
| CAediting_419718 | chr5_87397231_- | SINE | Alu | AluSx1 |
| CAediting_419719 | chr5_87397297_- | SINE | Alu | AluSx1 |
| CAediting_419720 | chr5_87397298_- | SINE | Alu | AluSx1 |
| CAediting_419721 | chr5_87398784_- | SINE | Alu | AluY |
| CAediting_419722 | chr5_87398792_- | SINE | Alu | AluY |
| CAediting_419723 | chr5_87406539_- | DNA | TcMar-Tigger | Tigger4a |
Top |
RNA A-to-I editing events in the alternative splicing sites for CCNH |
| RNA A-to-I editing(s) in the alternative splicing sites. |
| AStype | CAeditomID | Editing position | AS position | AS direction | Exonic location | Wildtype sequence | Wildtype splicing strength | RNA edited sequence | RNA edited splicing strength |
| IR | CAediting_419710 | chr5_87394304_- | 87394304:87394326 | 3SS | 3+0i | GTTTTCTTTCCCTTTCACAGTAA | 9.29 | GTTTTCTTTCCCTTTCACAGTAG | 8.58 |
| Differential percent of spliced in (PSI) between RNA A-to-I edited and non-edited samples for ENSG00000134480.12.CCNH. |
| Correlation between RNA A-to-I editing and PSI for ENSG00000134480.12.CCNH. |
Top |
Differntial gene expression between RNA A-to-I edited versus non-edited samples for CCNH |
| Differential gene expressions between RNA A-to-I edited and non-edited tumor samples. * The grey color means N/A. |
| Correlation between RNA A-to-I editing and gene expression. |
| - Differentially expressed gene between RNA A-to-I edited samples versus non-edited samples. * Click on the image to enlarge it in a new window. |
Top |
Protein coding region RNA A-to-I editings for CCNH |
| - Lollipop plot for RNA A-to-I editings across protein structure. * Click on the image to enlarge it in a new window. |
 |
Top |
The effects of the RNA editing to the miRNA binding sites for CCNH |
| **If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page. |
| RNA A-to-I editing in the 3'-UTR regions of mRNA gained miRNA binding sites. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320a-3p | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394320 | 151.00 | -21.11 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320b | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394320 | 151.00 | -21.11 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320b | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394320 | 151.00 | -21.11 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320c | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394318 | 146.00 | -20.84 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320c | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394318 | 146.00 | -20.84 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320d | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394317 | 141.00 | -17.08 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-320d | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394317 | 141.00 | -17.08 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-4429 | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394318 | 146.00 | -17.13 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-9-3p | 87394299 | 87394305 | 7mer-m8 | 87394298 | 87394322 | 149.00 | -12.31 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-9-3p | 87394299 | 87394305 | 7mer-m8 | 87394298 | 87394322 | 149.00 | -12.31 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-9-3p | 87394299 | 87394305 | 7mer-m8 | 87394298 | 87394322 | 149.00 | -12.31 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320a-3p | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394320 | 151.00 | -21.11 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320b | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394320 | 151.00 | -21.11 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320b | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394320 | 151.00 | -21.11 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320c | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394318 | 146.00 | -20.84 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320c | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394318 | 146.00 | -20.84 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320d | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394317 | 141.00 | -17.08 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-320d | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394317 | 141.00 | -17.08 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-4429 | 87394299 | 87394305 | 7mer-1a | 87394299 | 87394318 | 146.00 | -17.13 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-9-3p | 87394299 | 87394305 | 7mer-m8 | 87394298 | 87394322 | 149.00 | -12.31 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-9-3p | 87394299 | 87394305 | 7mer-m8 | 87394298 | 87394322 | 149.00 | -12.31 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-9-3p | 87394299 | 87394305 | 7mer-m8 | 87394298 | 87394322 | 149.00 | -12.31 |
| RNA A-to-I editing in the 3'-UTR regions of mRNA lost miRNA binding sites. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| CAediting_419709 | chr5_87394299_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-142-5p | 87394298 | 87394304 | 7mer-m8 | 87394297 | 87394317 | 140 | -11.17 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-548at-5p | 87394299 | 87394306 | 8mer-1a | 87394299 | 87394320 | 154 | -13.89 |
| CAediting_419709 | chr5_87394299_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-5590-3p | 87394298 | 87394304 | 7mer-m8 | 87394297 | 87394317 | 154 | -9.43 |
| CAediting_419709 | chr5_87394299_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-142-5p | 87394298 | 87394304 | 7mer-m8 | 87394297 | 87394317 | 140 | -11.17 |
| CAediting_419710 | chr5_87394304_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-548at-5p | 87394299 | 87394306 | 8mer-1a | 87394299 | 87394320 | 154 | -13.89 |
| CAediting_419709 | chr5_87394299_- | ENSG00000134480.12 | ENST00000504878 | hsa-miR-5590-3p | 87394298 | 87394304 | 7mer-m8 | 87394297 | 87394317 | 154 | -9.43 |
| RNA A-to-I editing in lncRNA gained miRNA binding sites. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| RNA A-to-I editing in lncRNA lost miRNA binding sites. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| RNA A-to-I editing in miRNAs gained binding to lncRNA. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| RNA A-to-I editing in miRNAs lost binding to lncRNA. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| RNA A-to-I editing in miRNAs gained binding to the 3'-UTR region of mRNA. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| CAediting_748296 | chr10_51299626_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-605-3p | 87394085 | 87394091 | 7mer-m8 | 87394084 | 87394104 | 149 | -15.79 |
| CAediting_1229415 | chr17_67471547_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-548aa | 87394062 | 87394068 | 7mer-m8 | 87394061 | 87394085 | 140 | -9.35 |
| CAediting_228905 | chr2_188297554_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-561-3p | 87393863 | 87393869 | 7mer-m8 | 87393862 | 87393883 | 142 | -8.1 |
| CAediting_442554 | chr5_154685830_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-1303 | 87394961 | 87394967 | 7mer-m8 | 87394960 | 87394981 | 158 | -18.23 |
| CAediting_442554 | chr5_154685830_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-1303 | 87394770 | 87394776 | 7mer-m8 | 87394769 | 87394790 | 141 | -12.05 |
| CAediting_573001 | chr7_92204086_- | ENSG00000134480.12 | ENST00000508855 | hsa-miR-1285-5p | 87394648 | 87394654 | 7mer-m8 | 87394647 | 87394668 | 150 | -26.59 |
| RNA A-to-I editing in miRNAs lost binding to the 3'-UTR mRNA. |
| CAeditom_ID | Position | ENSG | ENST | miRNA | Targetscan start | Targetscan end | Targetscan score | Miranda start | Miranda end | Miranda score | Miranda energy |
| CAediting_442554 | chr5_154685830_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-1303 | 87394446 | 87394452 | 7mer-m8 | 87394445 | 87394464 | 145 | -11.68 |
| CAediting_228905 | chr2_188297554_+ | ENSG00000134480.12 | ENST00000508855 | hsa-miR-561-3p | 87394333 | 87394339 | 7mer-m8 | 87394332 | 87394354 | 154 | -3.7 |
| Differentially expressed gene-miRNA network |
Top |
The effects of the RNA editing to the stability of the RNA structures for CCNH |
| - RNA A-to-I editing in mRNA. * Click on the image to enlarge it in a new window. |
| ENST | ENST type | RNA structure without RNA A-to-I editing. | RNA structure with RNA A-to-I editing. |
| ENST00000505587.4 | retained_intron |  |  |
| ENST00000508855.4 | protein_coding |  |  |
| ENST00000256897.7 | protein_coding |  |  |
| ENST00000504878.1 | protein_coding |  |  |
| ENST00000511207.4 | retained_intron |  |  |
| ENST00000513499.4 | processed_transcript |  |  |
| ENST00000505230.1 | retained_intron |  |  |
| ENST00000510020.4 | processed_transcript |  |  |
| RNA A-to-I editing in RNA structures for Minimum free energy (MFE). |
| CAeditom_ID | ENST | Editing_Position | MFE_withoneAI | MFE_withoutAI | MFE_withmultipleAI |
| CAediting_419704 | ENST00000505587.4 | chr5_87392498_- | -448.70 | -448.70 | -449.30 |
| CAediting_419705 | ENST00000505587.4 | chr5_87392511_- | -449.30 | -448.70 | -449.30 |
| CAediting_419706 | ENST00000505587.4 | chr5_87392512_- | -448.40 | -448.70 | -449.30 |
| CAediting_419707 | ENST00000508855.4 | chr5_87394110_- | -543.20 | -540.40 | -548.60 |
| CAediting_419708 | ENST00000508855.4 | chr5_87394295_- | -545.90 | -540.40 | -548.60 |
| CAediting_419709 | ENST00000508855.4 | chr5_87394299_- | -543.40 | -540.40 | -548.60 |
| CAediting_419710 | ENST00000508855.4 | chr5_87394304_- | -540.80 | -540.40 | -548.60 |
| CAediting_419708 | ENST00000256897.7 | chr5_87394295_- | -369.80 | -364.30 | -369.90 |
| CAediting_419709 | ENST00000256897.7 | chr5_87394299_- | -367.30 | -364.30 | -369.90 |
| CAediting_419710 | ENST00000256897.7 | chr5_87394304_- | -364.40 | -364.30 | -369.90 |
| CAediting_419724 | ENST00000256897.7 | chr5_87412772_- | -364.80 | -364.30 | -369.90 |
| CAediting_419708 | ENST00000504878.1 | chr5_87394295_- | -401.90 | -397.50 | -402.00 |
| CAediting_419709 | ENST00000504878.1 | chr5_87394299_- | -399.40 | -397.50 | -402.00 |
| CAediting_419710 | ENST00000504878.1 | chr5_87394304_- | -397.70 | -397.50 | -402.00 |
| CAediting_419724 | ENST00000504878.1 | chr5_87412772_- | -397.70 | -397.50 | -402.00 |
| CAediting_419708 | ENST00000511207.4 | chr5_87394295_- | -81.90 | -77.90 | -82.70 |
| CAediting_419709 | ENST00000511207.4 | chr5_87394299_- | -80.20 | -77.90 | -82.70 |
| CAediting_419710 | ENST00000511207.4 | chr5_87394304_- | -78.60 | -77.90 | -82.70 |
| CAediting_419724 | ENST00000513499.4 | chr5_87412772_- | -168.20 | -168.50 | -168.20 |
| CAediting_419724 | ENST00000505230.1 | chr5_87412772_- | -146.50 | -146.90 | -146.50 |
| CAediting_419724 | ENST00000510020.4 | chr5_87412772_- | -158.10 | -157.20 | -158.10 |
Top |
Relation with ADAR for CCNH |
| Correlation between ADAR gene expression and RNA editing frequency |
| Cancer | CAeditomID | position | ADAR1 (p-val) | ADAR1 (coeff.) | ADAR2 (p-val) | ADAR2 (coeff.) | ADAR3 (p-val) | ADAR3 (coeff.) |
Top |
Relation with cancer stages for CCNH |
| Correlation between Cancer stages and RNA editing frequency |
| Cancer | Stage_type | CAeditomID | position | P-val | Coeff. |
Top |
Relation with survival for CCNH |
| Correlation between RNA editing and survival |
| Cancer | CAeditomID | position | KMpvalue | Coxpvalue | CoxHR |
Top |
RelatedDrugs for CCNH |
| Approved drugs targeting this gene. (DrugBank Version 5.1.8 2021-01-03) |
| Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CCNH |
| Diseases associated with this gene. (DisGeNet 7.0) |
| Gene | Disease ID | Disease name | # pubmeds | Source |
| CCNH | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| CCNH | C0007097 | Carcinoma | 1 | CTD_human |
| CCNH | C0007102 | Malignant tumor of colon | 1 | CTD_human |
| CCNH | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
| CCNH | C0009375 | Colonic Neoplasms | 1 | CTD_human |
| CCNH | C0014859 | Esophageal Neoplasms | 1 | CTD_human |
| CCNH | C0017636 | Glioblastoma | 1 | CTD_human |
| CCNH | C0023903 | Liver neoplasms | 1 | CTD_human |
| CCNH | C0024232 | Lymphatic Metastasis | 1 | CTD_human |
| CCNH | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| CCNH | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| CCNH | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| CCNH | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
| CCNH | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
| CCNH | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
| CCNH | C0205699 | Carcinomatosis | 1 | CTD_human |
| CCNH | C0334588 | Giant Cell Glioblastoma | 1 | CTD_human |
| CCNH | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
| CCNH | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| CCNH | C0546837 | Malignant neoplasm of esophagus | 1 | CTD_human |
| CCNH | C0678222 | Breast Carcinoma | 1 | CTD_human |
| CCNH | C0919267 | ovarian neoplasm | 1 | CTD_human |
| CCNH | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
| CCNH | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
| CCNH | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| CCNH | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| CCNH | C1621958 | Glioblastoma Multiforme | 1 | CTD_human |
| CCNH | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
